CEDOC
ActiveSummary
CEDOC has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€76,993) and a net result of -€5,234. Equity is shrinking by about 5.4% per year across the filed financial years. Its solvency ranks better than 5% of 3,317 sector peers (NACE 62, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
29-07
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
26-08
NBB filing
Annual accounts filed
financial year 2024 · full format · 26 days late
2024
14-08
NBB filing
Annual accounts filed
financial year 2023 · full format · 14 days late
2023
31-12
Financial
Highest result from 2018 to 2025net €17,343 ▲298%
Operating result €17,611, net result €17,343, both a record.
13-07
NBB filing
Annual accounts filed
financial year 2022 · full format
2022
31-12
Financial
Back to profitnet €4,360
Net result €4,360 after 4 loss-making years.
24-08
NBB filing
Annual accounts filed
financial year 2021 · full format · 24 days late
2021
29-10
NBB filing
Annual accounts filed
financial year 2020 · full format · 90 days late
2020
31-12
Financial
Weakest financial yearnet -€73,725
Net result drops to -€73,725, the lowest in the series; recovery starts the following year.
10-07
NBB filing
Annual accounts filed
financial year 2019 · full format
2019
18-07
NBB filing
Annual accounts filed
financial year 2018 · full format
2018
30-07
NBB filing
Annual accounts filed
financial year 2017 · full format
2017
31-08
NBB filing
Annual accounts filed
financial year 2016 · full format · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 25 annual accounts filed, the latest 10 are here; all 25 are under Financials.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.